CRA-2059

CAT: 0804-HY-19303Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-19303Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
CRA-2059 is a highly specific and selective tryptase inhibitor, with a Ki of 620 pM for recombinant human tryptase-β (rHTβ) [1][2].
CAS Number
[256649-36-2]
UNSPSC
12352005
Target
Ser/Thr Protease
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/cra-2059.html
Solubility
10 mM in DMSO
Smiles
NC(NC1=CC=C(CNC(N2CCN(C(O[C@@H]3COC4[C@H](OC(N5CCN(C(NCC6=CC=C(NC(N)=N)C=C6)=O)CC5)=O)COC34)=O)CC2)=O)C=C1)=N
Molecular Formula
C34H46N12O8
Molecular Weight
750.80
References & Citations
[1]Tremaine WJ, et al. Treatment of mildly to moderately active ulcerative colitis with a tryptase inhibitor (APC 2059) : an open-label pilot study. Aliment Pharmacol Ther. 2002;16 (3) :407-413.|[2]Selwood T, et al. Potent bivalent inhibition of human tryptase-beta by a synthetic inhibitor. Biol Chem. 2003;384 (12) :1605-1611.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-117647CRA-19156
HY-19754CRA-026440
HY-19754A-01CRA-026440 (hydrochloride)
HY-133533O-2050
HY-176084RJG-2051
HY-149862-01ARD-2051
HY-161617LASSBio-2052
HY-121008Brl 20596
HY-D0118A-205
HY-103498AOrg 20599 (methanesulfonate)

Alternative Products

CatalogName
MBS5800480CRA-2059
T38052CRA-2059 TFA
MBS5798798CRA-2059 hydrochloride
C07285-01Tegatrabetan (BC-2059)
MBS387053-01CRA-026440
T27081-01CRA-19156
A10T15Recombinant Cra a 2
A12179-50CRA-026440 50mg
A10T14Recombinant Cra a 1
E4A10T16Recombinant Cra a 4

Popular Products